Stay updated on Magrolimab + Azacitidine after Allo-HCT in High-Risk AML/MDS Clinical Trial

Sign up to get notified when there's something new on the Magrolimab + Azacitidine after Allo-HCT in High-Risk AML/MDS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Magrolimab + Azacitidine after Allo-HCT in High-Risk AML/MDS Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The Record History now includes a new revision entry (Revision: v3.3.3) and removes the HHS Vulnerability Disclosure and the previous Revision: v3.3.2 entries. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-21T21:34:27.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    A new revision entry v3.3.2 is added to the Record History and the previous revision v3.3.1 is removed from the listing. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-30T07:33:04.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The Record History now includes a new revision entry for v3.3.1, replacing v3.2.0, as part of standard page update activity. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-23T08:14:48.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The notice about government funding and NIH operating status was removed from the page, eliminating the maintenance alert. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.8%
    Check dated 2025-11-16T06:12:36.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    Versions 2, 3, and 4 show updates to Study Status and Recruitment Status, reflecting the trial's progression and changes in recruitment.
    Difference
    0.1%
    Check dated 2025-11-02T00:36:34.000Z thumbnail image
  9. Check
    103 days ago
    Change Detected
    Summary
    Major change: page now includes a funding/status notice and a new v3.2.0 revision, replacing v3.0.2.
    Difference
    13%
    Check dated 2025-10-04T08:04:47.000Z thumbnail image

Stay in the know with updates to Magrolimab + Azacitidine after Allo-HCT in High-Risk AML/MDS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Magrolimab + Azacitidine after Allo-HCT in High-Risk AML/MDS Clinical Trial page.